68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study-Reference-Cited by-同舟云学术

68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study

Published:2017-04-13 Issue:10 Volume:58 Page:1617-1623
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Fendler Wolfgang Peter,Calais Jeremie,Allen-Auerbach Martin,Bluemel Christina,Eberhardt Nina,Emmett Louise,Gupta Pawan,Hartenbach Markus,Hope Thomas A.,Okamoto Shozo,Pfob Christian Helmut,Pöppel Thorsten D.,Rischpler Christoph,Schwarzenböck Sarah,Stebner Vanessa,Unterrainer Marcus,Zacho Helle D.,Maurer Tobias,Gratzke Christian,Crispin Alexander,Czernin Johannes,Herrmann Ken,Eiber Matthias

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference41 articles.

1. 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

2. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

3. Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis

4. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis;Perera;Eur Urol.,2016

5. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

2. Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma;Molecular Imaging and Biology;2024-08-01

3. Fibroblast Activation Protein–Directed Imaging Outperforms¹⁸F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial;Journal of Nuclear Medicine;2024-07-03

4. Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-01

5. Impact of ⁶⁸Ga-PSMA PET/CT on Survival and Management in Prostate Cancer;Current Medical Imaging Formerly Current Medical Imaging Reviews;2024-04-26